Abstract
Hepatocellular carcinoma (HCC) is a leading cause of cancer morbidity and mortality worldwide. Common sites of metastases include the lungs, regional lymph nodes, bone, and adrenal glands. Although rare, distant metastases to the cervical lymph nodes have been reported. With better therapies for viral hepatitis, there has been a shift in the landscape of chronic liver disease and the development of HCC with rising prevalence of HCC attributable to metabolic dysfunction-associated steatotic liver disease. In this study, we describe a case of metastatic HCC presenting as cervical lymphadenopathy in a patient with metabolic dysfunction-associated steatotic liver disease in the absence of cirrhosis.